# FDA recall D-1023-2018

> **PFIZER** · Class II · drug recall initiated 2018-06-28.

## Product

Daptomycin for Injection, 500 mg per vial, packaged as 1 Single-dose vial per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-0106-01.

## Reason for recall

Microbial Contamination of Sterile Products: Product associated with reports of adverse events indicative of infusion reactions related to microbiological contamination.

## Distribution

Nationwide in the USA and Puerto Rico.

## Key facts

- **Recall number:** D-1023-2018
- **Recalling firm:** PFIZER
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2018-06-28
- **Report date:** 2018-08-08
- **Termination date:** 2022-08-25

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lake Forest, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1023-2018

## Citation

> AI Analytics. FDA recall D-1023-2018. Retrieved 2026-05-28 from https://api.ai-analytics.org/recall/D-1023-2018. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*